🇺🇸 FDA
Pipeline program

ILUVIEN 0.19 MG

M-01-15-004

Approved small_molecule completed

Quick answer

ILUVIEN 0.19 MG for Diabetic Macular Edema (DME) is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ANI PHARMACEUTICALS INC
Indication
Diabetic Macular Edema (DME)
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials